+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | Transforming Growth Factor Beta 1 (TGFb1) |
| Research Area | Cytokines, Tumor Immunity, Infection Immunity, Cancer |
| Origin | Human |
| Host | CHO cells |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Biological Activity | Specific Activity: ≥ 2 × 107 U/mg. The ED50, as determined by the ability of TGF beta 1 to inhibit the IL-4 -dependent proliferation of Mouse HT-2 cells was determined to be less than or equal to 0.05 ng/ml. |
| Purity | > 98% (SDS-PAGE/HPLC) |
| Reconstitution | Reconstitute in 100 µl sterile H2O. Further dilutions should be made with a buffer containing a carrier protein such as 0.1% BSA. Do not vortex. |
| Storage | Store lyophilized at 4°C. Store reconstituted at -20°C. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 12 months. |
| UniProt Primary AC | P01137 (UniProt, ExPASy) |
| UniProt Secondary AC | A8K792, Q9UCG4 |
| UniProt Entry Name | TGFB1_HUMAN |
| Gene Symbol | TGFB1 |
| KEGG | hsa:7040 |
| String | 9606.ENSP00000221930 |
| Molecular Weight | 25.0 kDa |
| Endotoxin Level | < 0.1 ng/µg |
| Concentration | Lyophilized form: Not applicable. After reconstitution: 0.1 mg/ml. |
| Availability | Shipped within 3-7 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
| Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |